Harmony Consulting Blog
Scaling a promising therapeutic from lab bench to commercial production is one of the most defining transitions in a biotech’s lifecycle. It’s also one of the most closely scrutinized. As…
When the federal government shuts down, Washington D.C. doesn’t actually close — it constricts. For biotech organizations that rely on federal grants, contracts, regulatory interactions or collaborations with government-labs, a…